A Phase 2 Study With MIP-1404 in Men With High-Risk PC Scheduled for RP and EPLND Compared to Histopathology

PHASE2CompletedINTERVENTIONAL
Enrollment

105

Participants

Timeline

Start Date

August 31, 2012

Primary Completion Date

December 31, 2013

Study Completion Date

December 31, 2013

Conditions
Prostate Cancer
Interventions
DRUG

Drug: 99mTc-MIP-1404

A single dose of 20 ±3 mCi intravenous (IV) injection of 99mTc-MIP-1404

Trial Locations (35)

3000

University Hospitals Leuven, Leuven

8991

Bajcsy-Zsilinszky Hospital, Department of Urology, Budapest

10021

New York Presbyterian Hospital - Cornell, New York

10126

University of Turin, Torino

15006

University Hospital Motol, Clinic of Urology, Prague

19107

Thomas Jefferson University / Jefferson Urology Associates, Philadelphia

20132

Vita-Salute University San Raffaele, Milan

27710

Duke University Medical Center, Durham

29435

Medical University of South Carolina, Charleston

30599

University Hospital Plzen, Department of Urology, Pilsen

44195

Glickman Urology & Kidney Institute, Cleveland Clinic, Cleveland

50981

4th Military Teaching Hospital and Polyclinic,, Wroclaw

51124

"Provincial Specialist Hospital in Wroclaw, Department of Urology", Wroclaw

53792

University of Wisconsin, Madison

55905

Mayo Clinic, Rochester

77030

University of Texas Vanguard Urologic Research Foundation, Houston

80952

University Clinical Centre, Department of Urology, Gdansk

91010

City of Hope National Cancer Center, Duarte

98109

University of Washington School of Medicine, Seattle

105077

City Clinical Hospital # 57, Moscow

115478

"Federal Public State Institution Russian Oncology Research Center n.a. N.N. Blokhin under the Russian Academy of medical sciences", Moscow

125284

Moscow Oncology Research Institute n.a. P.A. Hertsen, Moscow

197374

All-Russia Centre for Urgent Care and Radiation Medicine named after A.M. Nikiforov under the Ministry of the Russian Federation for Civil Defence, Emergencies and Elimination of Consequences of Natural Disasters, Saint Petersburg

197758

Federal State Public Institution Russian Research center for Radiology and Surgical Technologies under the Federal agency for High-tech medical care, Saint Petersburg

Research Institute of Oncology n.a. Professor N.N. Petrov under the Federal Agency for Healthcare and Social Development, Saint Petersburg

198255

"St. Petersburg State Public Medical Institution: Clinical Oncological Center", Saint Petersburg

249036

"Federal State Public Institution Medical Radiology Research Center of Healthcare Ministry and Social Development of Russian Federation", Obninsk

779 00

University Hospital Olomouc, Clinic of Urology, Olomouc

128 08

General University Hospital in Prague, Clinic of Urology, Prague

140 59

Thomayer's Hospital, Prague

180 01

Hospital Na Bulovce, Department of Urology, Prague

H-1076

Peterfy Sandor Street Hospital, Department of Urology, Budapest

H1204

Jahn Ferenc South Pest Hospital, Department of Urology, Budapest

6525 GA

UMC St. Radboud Nijmegen, Nijmegen

00909

University Hospital Plzen, Department of Urology, Warsaw

All Listed Sponsors
lead

Molecular Insight Pharmaceuticals, Inc.

INDUSTRY